Baker Avenue Asset Management’s GSK GSK Stock Holding History

Baker Avenue Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-74	Closed	-$2.63K	–	1635
2023 Q2	$2.63K	Buy	74 +12	+19%	+$430	﹤0.01%	935
2023 Q1	$2.21K	Buy	+62	New	+$2.17K	﹤0.01%	971
2022 Q1	–	Sell	-5,575	Closed	-$307K	–	302
2021 Q4	$307K	Buy	5,575 +1,359	+32%	+$70.7K	0.02%	263
2021 Q3	$201K	Buy	+4,216	New	+$212K	0.01%	253

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baker Avenue Asset Management's GSK Position: Q3 2023 in Review

Baker Avenue Asset Management sold out of GSK (GSK) in Q3 2023, closing a stake of 74 shares — an estimated $2.63K sold.

Baker Avenue Asset Management first reported a position in GSK in Q3 2021 and held it in 4 quarters. The position peaked at $307K in Q4 2021. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Baker Avenue Asset Management reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Baker Avenue Asset Management sold 74 GSK shares in Q3 2023, an estimated $2.63K.
Baker Avenue Asset Management first reported a position in GSK in Q3 2021 and held it in 4 quarters.
Baker Avenue Asset Management's GSK position peaked at $307K in Q4 2021.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Baker Avenue Asset Management's 13F filing for Q3 2023, filed 15 Nov 2023.